Charles Conover
2012
In 2012, Charles Conover earned a total compensation of $585.1K as Former Senior Vice President of Research & Development, Program Management at Enzon Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $72,450 |
|---|---|
| Option Awards | $56,538 |
| Salary | $297,118 |
| Stock Awards | $151,525 |
| Other | $7,500 |
| Total | $585,131 |
Conover received $297.1K in salary, accounting for 51% of the total pay in 2012.
Conover also received $72.5K in non-equity incentive plan, $56.5K in option awards, $151.5K in stock awards and $7.5K in other compensation.
Rankings
In 2012, Charles Conover's compensation ranked 8,224th out of 11,487 executives tracked by ExecPay. In other words, Conover earned more than 28.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,224 out of 11,487 | 28th |
Division Manufacturing | 2,974 out of 4,253 | 30th |
Major group Chemicals And Allied Products | 788 out of 1,198 | 34th |
Industry group Drugs | 563 out of 920 | 39th |
Industry Biological Products, Except Diagnostic Substances | 92 out of 160 | 43rd |
Source: SEC filing on April 16, 2014.
Conover's colleagues
We found five more compensation records of executives who worked with Charles Conover at Enzon Pharmaceuticals in 2012.
2012
Ana Stancic
Enzon Pharmaceuticals
Chief Financial Officer
2012
Andrew Rackear
Enzon Pharmaceuticals
General Counsel
2012
Aby Buchbinder
Enzon Pharmaceuticals
Former Vice President, Clinical Development
2012
George Hebard
Enzon Pharmaceuticals
Chief Operating Officer
2012
Timothy Daly
Enzon Pharmaceuticals